The forces of cancer by Sero, Julia & Bakal, Chris
        
Citation for published version:
Bakal, C & Sero, J 2019, 'The forces of cancer', Philosophical Transactions of the Royal Society B: Biological
Sciences, vol. 374, no. 1779, 20190103, pp. 1-3. https://doi.org/10.1098/rstb.2019.0103
DOI:
10.1098/rstb.2019.0103
Publication date:
2019
Document Version
Peer reviewed version
Link to publication
University of Bath
General rights
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners
and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights.
Take down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Download date: 07. Dec. 2019
  
 
 
 
 
 
 
 
 
 
The forces of cancer 
 
 
Chris Bakal and Julia Sero 
 
Chris Bakal, Chester Beatty Laboratories, 237 Fulham Road, London, UK, SW3 6JB 
 
Julia Sero University of Bath, Claverton Down, Bath UK, BA2 7AY 
 
 
  
 2 
 
A tumour is a dysfunctional cellular community. Not only does mutation lead to uncontrolled 
proliferation, radical shape changes, and identity crises in cancer cells - many other cell types are 
corrupted by the bad influence of the tumour, engaging in malicious behaviours that aid tumour cells 
directly and disrupt normal organ functions. The actions of multiple cell types in a tumour eventually 
make their own environment uninhabitable, leading to a toxic sprawl that spreads throughout the 
tissue and ultimately the body. In some cases, cancer cells – with the assist of other cell types such as 
cancer associated fibroblasts (CAFs) – can leave the primary tumour and start the process anew in 
distant tissues. Despite all we know about cancer, a number of key questions remain to be answered, 
not least about the role of the physical microenvironment. How do the various cell types in a tumour 
make sense of their surroundings, in particular by transmitting mechanical information from the 
external matrix into nuclei? How do cancer cells communicate with each other over long distances 
within and between tissues? And how do tumours promote the wide-ranging structural remodelling 
seen in primary tissues and metastatic sites? 
  
The theme of the “Forces In Cancer” Hooke Meeting held over two sunny days during 2018 in London, 
was how information is propagated within cells and between cell occurs via mechanical forces.  Cells in 
and around tumours are constantly being pushed, pulled, pressed, and squeezed, both by other cells 
and by the extracellular matrix (ECM). The constant demolition and reconstruction of the ECM by 
cancer cells and others, such as tumour-associated macrophages and CAFs, represents a particular 
mode of information transmission, where cells change their environment as a way to direct the 
behaviour of other cells.  
 
In this special issue, speakers at this meeting have contributed reviews from their unique perspectives, 
opinion pieces, and original research centred on the role of mechanical forces in tumourigenesis and 
metastasis.  
 
Cellular organelles as mechanotransducers 
 
Keith Burridge, a pioneer in the field of mechanobiology, discusses mechanotransduction on the cellular 
scale, specifically how cell surface receptors transmit signals to the nucleus via mechanical tension and 
Rho GTPases (Burridge et al, this issue). Critical to this information propagation paradigm is the concept 
of the nucleus itself as a semi-rigid mechanoresponsive element. Pere Rocha-Cosachs and colleagues 
discuss the plasma membrane as a mechanochemical transducer, illustrating how the lipid bilayer and 
its protein components respond and adapt to tensile and shear stresses (Le Roux et al, this issue).  
 
Influences of mechanical forces of the dynamics of cellular processes 
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Cells not only sense mechanical forces, but respond by altering cancer-relevant behaviours such as 
proliferation, differentiation, inflammation, and drug resistance. Martin Humphries and colleagues 
discuss how force sensing regulates progression through the cell cycle, providing mechanistic insights 
that explain how proliferation of tumours is driven by increased ECM stiffness (Jones et al, this issue). 
Similarly, Sasha Bershadsky and colleagues provide novel experimental insights into how myosin II and 
plasma membrane tension modulate podosome dynamics (Rafiq et al, this issue).   
 
Tumour cell migration in mechanically complex environments 
 
Cancer cell migration was a recurring theme in the “Forces in Cancer” symposium because the 
engagement of migratory programmes underpins tumour metastasis. This themed issue tackles the 
subject of tumour cell motility in a number of different contexts. Benny Geiger and colleagues 
contribute new research showing how cross-talk between the stroma and tumor cells promotes tumour 
cell migration via synergistic effects of cytokines (Elisha et al, this issue). Giorgio Scita and colleagues 
provide a thought-provoking piece discussing whether migration is indeed a selectable trait that occurs 
during tumour evolution (Disanza et al, this issue). Because tumour cell migration in the body occurs in 
complex 3D environments with diverse mechanical and geometric properties, developing new model 
systems that mimic these environments is an important challenge for cancer biology research. Jan 
Lammerding and Noam Zuela-Sopilniak review the state-of-the-art in these systems (Zuela-Sopilniak 
and Lammerding, this issue), and Katrina Wolf and colleagues provide original research showing how 
the morphological alterations that occur during 3D migration underpin migratory speed and 
acceleration (Krause et al, this issue). Notably, cell migration in 3D depends strongly on the mechanical 
properties of the nucleus, underscoring its importance as a mechanotransducing element. 
 
Bioengineering approaches in tumour mechanobiology 
 
Cancer mechanobiology research is an inherently and increasingly multidisciplinary endeavour. From 
hydrogels, to microfluidic devices, to complex organ-on-chip platforms, the last decade has witnessed 
an explosion of new materials and devices that have been engineered to more closely recapitulate 
features of the tumour microenvironment for fundamental research, diagnostic, and drug discovery 
applications. However, a challenge to working with these models is quantifying both the phenotypes 
themselves, as well as different parameters of the systems itself (i.e. hydrogel stiffness). In this issue, 
Val Weaver and colleagues survey current methods for quantifying ECM and cell mechanics at different 
scales, with a particular focus on brain and CNS tumours (Ayad et al, this issue). Shelley Peyton and 
colleagues discuss new metrics for assessing the response of cancer cells in hydrogel and co-culture 
matrices to small-molecule treatments from an engineering perspective (Brooks et al, this issue). The 
utility and challenges of mathematical modelling in cancer biology are also recurring themes 
throughout this issue.  
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Leveraging cancer mechanobiology to develop new therapeutics  
 
The ultimate goal of tumour biology research is to devise new ways to cure and prevent cancer. Given 
the current excitement regarding immune modulators as cancer therapeutics, it is no surprise that 
interplay of cell-cell and cell-ECM mechanical cross-talk was a hot topic of the meeting. The ECM plays 
a complex role in immune cell modulation, and as such represents a potential avenue for engaging the 
body’s own defence mechanisms against tumours, but also a new set of challenges for immunotherapy. 
In this issue, Sophie Acton and colleagues review literature on how the ECM both can impede and 
promote immune cell infiltration and activation in solid tumours (Martinez et al, this issue). Dennis 
Discher and colleagues posit that the softness of cancer cells could allow them to evade engulfment by 
macrophages, and discuss how blocking CD47 could circumvent this mechanical barrier (Andrechak et 
al, this issue). 
 
Conclusion  
 
While this issues highlights both the recent progress that has been made in cancer mechanobiology, 
and points to the future, the authors also address some intellectual and technology challenges that 
must be overcome in order to get better understanding of forces in cancer. Perhaps foremost amongst 
these is the development of research models that better mimic the complex nature of tumours – both 
in terms of cellular diversity, complex geometry, and dynamic mechanics. But importantly, such models 
must allow analytics on the single cell level; especially quantitative imaging approaches. We believe 
that continued discussion between bioengineers, physicists, imaging specialists and cancer biologists is 
thus essential is driving the field of tumor mechanobiology forward, and most opportunities for 
establishing collaborations between these fields should exist. 
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